BIO-TECHNE Corp vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? BIO-TECHNE Corp trades at $71.63 (market cap $11.16B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.7. The key difference: BIO-TECHNE Corp pays a 0.45% dividend while Roundhill S&P 500 0DTE Covered Call Strategy ETF pays none, and BIO-TECHNE Corp is trading nearer its 52-week high, Roundhill S&P 500 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals.
| TECH | XDTE | |
|---|---|---|
Market Cap | $11.16B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $72.12 | $44.76 |
52-Week Low | $43.31 | $36.00 |
Enterprise Value | $11.24B | — |
Dividend Yield | 0.45% | — |
Trailing returns across standard periods
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →